Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul G. Richardson
Patient-Reported Outcomes of Multiple Myeloma Patients Treated With Panobinostat After ≥2 Lines of Therapy Based on the International Phase 3, Randomized, Double-Blind, Placebo-Controlled PANORAMA-1 Trial
British Journal of Haematology
Hematology
Recurrent Cardiotoxicity Potentiated by the Interaction of Proteasome Inhibitor and Immunomodulatory Therapy for the Treatment of Multiple Myeloma
British Journal of Haematology
Hematology
Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome With Multi-Organ Dysfunction: A Concordance Analysis Between Day+100 Complete Response and Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes With Defibrotide Following Hematopoietic Cell Transplantation in Adult and Pediatric Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update From the International Compassionate Use Program in 710 Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Pooled Analysis of Survival by Defibrotide (DF) Timing of Initiation in Adults With Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Efficacy and Safety of Defibrotide in a Subset Analysis of Late-Onset Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Patients From an Ongoing, Expanded-Access Program
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Phase 1 Study of the Protein Deubiquitinase Inhibitor VLX1570 in Patients With Relapsed and/or Refractory Multiple Myeloma
Investigational New Drugs
Oncology
Pharmacology
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
PLoS ONE
Multidisciplinary
Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
PLoS ONE
Multidisciplinary
‹
1
2
3
›
